SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010244
Filing Date
2021-08-04
Accepted
2021-08-04 16:40:06
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptgx-20210630x10q.htm   iXBRL 10-Q 2048502
2 EX-31.1 ptgx-20210630xex31d1.htm EX-31.1 10122
3 EX-31.2 ptgx-20210630xex31d2.htm EX-31.2 9948
4 EX-32.1 ptgx-20210630xex32d1.htm EX-32.1 9491
5 GRAPHIC ptgx-20210630x10q007.jpg GRAPHIC 109484
  Complete submission text file 0001558370-21-010244.txt   8442629

Data Files

Seq Description Document Type Size
6 EX-101.SCH ptgx-20210630.xsd EX-101.SCH 64609
7 EX-101.CAL ptgx-20210630_cal.xml EX-101.CAL 51199
8 EX-101.DEF ptgx-20210630_def.xml EX-101.DEF 236419
9 EX-101.LAB ptgx-20210630_lab.xml EX-101.LAB 504823
10 EX-101.PRE ptgx-20210630_pre.xml EX-101.PRE 422583
11 EXTRACTED XBRL INSTANCE DOCUMENT ptgx-20210630x10q_htm.xml XML 1412146
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37852 | Film No.: 211144622
SIC: 2834 Pharmaceutical Preparations